JUPITER NEUROSCIENCES, INC.

JUNS · Nasdaq · SIC 2834: Pharmaceutical Preparations
45
SEC Filings

Business Summary

PART I This Business section, along with other sections of this Annual Report on Form 10-K, includes statistical and other industry and market data that we obtained from industry publications and research, surveys and studies conducted by third parties. Industry publications and third-party research, surveys and studies generally indicate that their information has been obtained from sources believed to be reliable, although they do not guarantee the accuracy or completeness of such information....

Next Earnings

Q2 FY2026 — expected 2026-07-09

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionJUNSdiscussed_in_filing Artificial Intelligence
topic_mentionJUNSdiscussed_in_filing Cybersecurity
topic_mentionJUNSdiscussed_in_filing Trusted Computing
topic_mentionJUNSdiscussed_in_filing Blockchain & Crypto
topic_mentionJUNSdiscussed_in_filing Regulation
topic_mentionJUNSdiscussed_in_filing Healthcare & Bio
topic_mentionJUNSdiscussed_in_filing Platform & Ecosystem
topic_mentionJUNSdiscussed_in_filing Artificial Intelligence
topic_mentionJUNSdiscussed_in_filing Cybersecurity
topic_mentionJUNSdiscussed_in_filing Trusted Computing
topic_mentionJUNSdiscussed_in_filing Blockchain & Crypto
topic_mentionJUNSdiscussed_in_filing Regulation
topic_mentionJUNSdiscussed_in_filing Healthcare & Bio
topic_mentionJUNSdiscussed_in_filing Platform & Ecosystem
topic_mentionJUNSdiscussed_in_filing Artificial Intelligence
topic_mentionJUNSdiscussed_in_filing Cybersecurity
topic_mentionJUNSdiscussed_in_filing Trusted Computing
topic_mentionJUNSdiscussed_in_filing Blockchain & Crypto
topic_mentionJUNSdiscussed_in_filing Regulation
topic_mentionJUNSdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-04-012025-12-310001493152-26-014687EDGAR110K words
2025-03-282024-12-310001641172-25-001261EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001493152-25-023603EDGAR22K words
2025-08-192025-06-300001641172-25-024684EDGAR—
2025-05-152025-03-310001641172-25-010990EDGAR—
2024-12-232024-09-300001493152-24-051847EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-270001493152-26-008344EDGAR2K words
2026-02-200001493152-26-007624EDGAR—
2025-12-230001493152-25-029124EDGAR—
2025-12-220001493152-25-028789EDGAR—
2025-10-270001493152-25-019783EDGAR—
2025-07-100001641172-25-018619EDGAR—
2025-07-090001641172-25-018429EDGAR—
2025-04-210001641172-25-005506EDGAR—
2025-03-250001641172-25-000627EDGAR—
2024-12-200001493152-24-050881EDGAR—

45 total filings indexed. 29 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001679628
TickerJUNS
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: dfa23bd0107b9c08ed4eb381c176015b8533e0973bc00d9eb017d0dfcf6b9552
parent: ab453439b350f6d151c6bfb5610a9fe6dd4d679bd3fd1ad36342417526580038
content hash: dbaeb68c93c9d9e571101d91a345fd45bbcf2e75de10b6d0ccf8279c2a29afc1
signed: 2026-04-13T04:45:50.563Z
sources: 6 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf